DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 156 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $36,291,000 | -7.2% | 1,068,000 | 0.0% | 0.57% | -16.2% |
| Q2 2021 | $39,099,000 | -2.4% | 1,068,000 | +19.6% | 0.68% | -1.7% |
| Q1 2021 | $40,042,000 | -46.0% | 893,000 | -31.3% | 0.69% | -45.9% |
| Q4 2020 | $74,191,000 | -20.5% | 1,300,000 | -28.6% | 1.28% | -3.7% |
| Q3 2020 | $93,366,000 | -15.9% | 1,820,000 | -2.2% | 1.33% | -39.6% |
| Q2 2020 | $111,079,000 | +34.9% | 1,860,000 | -7.0% | 2.20% | -21.0% |
| Q1 2020 | $82,340,000 | +127.9% | 2,000,000 | +53.8% | 2.78% | +161.9% |
| Q4 2019 | $36,130,000 | – | 1,300,000 | – | 1.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 4,104,140 | $93,041,000 | 43.52% |
| SV Health Investors, LLC | 1,716,303 | $38,909,000 | 20.55% |
| PURA VIDA INVESTMENTS, LLC | 68,154 | $1,545,000 | 0.65% |
| Redmile Group, LLC | 683,880 | $14,658,000 | 0.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 77,000 | $1,746,000 | 0.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 224,154 | $5,008,000 | 0.59% |
| EMERALD ADVISERS, LLC | 482,626 | $10,941,000 | 0.42% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 416,342 | $9,438,000 | 0.38% |
| Orbimed Advisors | 1,176,070 | $26,662,000 | 0.34% |
| VIKING GLOBAL INVESTORS LP | 2,394,625 | $54,286,000 | 0.33% |